Rhode Island, January 9, 2023 — QualityMetric (QM), a leading global technology-enabled provider of patient-reported outcome (PRO) and clinical outcome assessment (COA) surveys and scientific consulting services, has reconfirmed its commitment to comply with GDPR (both EU General Data Protection Regulation 2016/679 and its UK counterpart).
These regulations are designed to provide individuals more control over their personal data and ensure that personal data is adequately protected when it is collected and processed by other parties. QM has thoroughly reviewed its compliance status and announces today that the business is in a state of compliance with EU GDPR and UK GDPR.
QM hired an external compliance firm to assess QM’s quality management system and a separate Data Protection Officer (DPO, MyData-TRUST) to support continued compliance. All identified remediation activities have been closed, to ensure a current state of EU GDPR and UK GDPR compliance.
“GDPR is a comprehensive privacy legislation that has an international scope and has a cross-functional impact. Compliance is a team effort. MyData-TRUST is happy to have accompanied QM to GDPR compliance and is proud of the accomplishments of QM,” stated Diana Văsar, DPO.
Tim Burks, Chief Technology Officer, added “This yearlong undertaking involved important contributions from individuals across all departments… Collectively, we now have a solid security and compliance program that meets our clients’ expectations and minimizes risk. We will continue to monitor security updates and the use of technology for ensuring continued data safety and data security.”
Data privacy and security are the new legislators of success for all global businesses. QualityMetric is in the vanguard for bringing Patient-Generated Evidence to the healthcare markets we serve.
QualityMetric works with the world’s leading healthcare and life sciences companies to measure and better understand outcomes through the creation, administration, and review of general and patient-specific health surveys. Founded in 1997, QM combines its proprietary scientifically validated general health and disease specific surveys with its enabling technology, advanced analytics, and sector expertise to work with all the world’s largest pharmaceutical companies in clinical trials and patient surveillance. For more information visit: QualityMetric.com
1301 Atwood Avenue, Suite 216E, Johnston, RI 02919
+1 (401) 903-4671